Education
About Us
Working with TipRanks
Follow Us
Gemina Laboratories Ltd. (TSE:GLAB)
:GLAB
RESEARCH TOOLSreports
Total Valuation
Gemina Laboratories Ltd. has a market cap or net worth of C$65.09M. The enterprise value is ―.
Market CapC$65.09M
Enterprise Value―
Share Statistics
Gemina Laboratories Ltd. has 76,570,910 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding76,570,910
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Gemina Laboratories Ltd.’s return on equity (ROE) is 3.29 and return on invested capital (ROIC) is 462.41%.
Return on Equity (ROE)3.29
Return on Assets (ROA)-3.58
Return on Invested Capital (ROIC)462.41%
Return on Capital Employed (ROCE)3.69
Revenue Per Employee0.00
Profits Per Employee-869.46K
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Gemina Laboratories Ltd. is -7.78. Gemina Laboratories Ltd.’s PEG ratio is -2.73.
PE Ratio-7.78
PS Ratio0.00
PB Ratio-22.82
Price to Fair Value-25.60
Price to FCF-63.96
Price to Operating Cash Flow-62.83
PEG Ratio-2.73
Income Statement
In the last 12 months, Gemina Laboratories Ltd. had revenue of 0.00 and earned -5.22M in profits. Earnings per share was -0.07.
Revenue0.00
Gross Profit-93.37K
Operating Income-5.09M
Pretax Income-5.22M
Net Income-5.22M
EBITDA-5.18M
Earnings Per Share (EPS)-0.07
Cash Flow
In the last 12 months, operating cash flow was -1.27M and capital expenditures 16.26K, giving a free cash flow of -1.24M billion.
Operating Cash Flow-1.27M
Free Cash Flow-1.24M
Free Cash Flow per Share-0.02
Dividends & Yields
Gemina Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.40
52-Week Price Change88.89%
50-Day Moving Average1.02
200-Day Moving Average0.74
Relative Strength Index (RSI)39.91
Average Volume (3m)4.88K
Important Dates
Gemina Laboratories Ltd. upcoming earnings date is Jun 26, 2025, TBA Not Confirmed.
Last Earnings DateMay 28, 2025
Next Earnings DateJun 26, 2025
Ex-Dividend Date―
Financial Position
Gemina Laboratories Ltd. as a current ratio of 0.03, with Debt / Equity ratio of -42.09%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap<0.01
Net Debt to EBITDA-0.09
Interest Coverage Ratio-264.05
Taxes
In the past 12 months, Gemina Laboratories Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Gemina Laboratories Ltd. EV to EBITDA ratio is -7.93, with an EV/FCF ratio of -12.50.
EV to Sales0.00
EV to EBITDA-7.93
EV to Free Cash Flow-12.50
EV to Operating Cash Flow-12.66
Balance Sheet
Gemina Laboratories Ltd. has C$41.61K in cash and marketable securities with C$1.46M in debt, giving a net cash position of C$1.42M billion.
Cash & Marketable SecuritiesC$41.61K
Total DebtC$1.46M
Net CashC$1.42M
Net Cash Per ShareC$0.02
Tangible Book Value Per Share-C$0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Gemina Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast50.85%